Resilience的封面图片
Resilience

Resilience

制药业

San Diego,CA 42,770 位关注者

A Revolution in the Making

关于我们

Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.

网站
https://www.resilience.com
所属行业
制药业
规模
1,001-5,000 人
总部
San Diego,CA
类型
私人持股
创立
2020
领域
Biomanufacturing、Gene Therapy、Cell Therapy、Vaccines、Biologics和Nucleic Acids

地点

Resilience员工

动态

  • 查看Resilience的组织主页

    42,770 位关注者

    Resilience is proud to sponsor the #DCAT 2025 Women’s Networking Breakfast. We had the privilege to hear from global change-maker and Founder of Copia Komal Ahmad, who shared her journey and vision to transform the world one innovative solution at a time. Stories like hers inspire us to pursue our mission to drive innovative biomanufacturing. Thanks DCAT (Drug, Chemical & Associated Technologies Association) & the other sponsors for a great morning!

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Resilience的组织主页

    42,770 位关注者

    Interested in exploring our Center of Excellence for fill/finish and device assembly and packaging in Cincinnati, Ohio? Now you can take a virtual tour of our Cincinnati facility right from your office! Discover our FDA-licensed site, featuring high-speed fill lines for vials, cartridges, and pre-filled syringes (PFS), with exciting new line expansions set for 2025. Plus, we're growing our device assembly and packaging suites. Discover an impressive site with a proud legacy of delivering commercial medicines across the globe. Take a tour today: https://hubs.ly/Q03bQTnG0

    • 该图片无替代文字
  • 查看Resilience的组织主页

    42,770 位关注者

    Every moment reduced in vein-to-vein time gives your autologous CAR-T cell therapy a better chance to do precisely what you designed it to do. Leveraging the Short Cycle CAR-T Manufacturing technology from Resilience, you can cut your manufacturing time down to just 3 days – all while capitalizing on the potency and persistence of both naive and central memory T cells. Wondering how this compares to conventional CAR-T manufacturing methods? Read our latest White Paper today: https://hubs.ly/Q03bQV6s0 #CellTherapy

  • 查看Resilience的组织主页

    42,770 位关注者

    There’s no template that demonstrates the step-by-step route of getting your product to the market, and we understand that process can be daunting. But you’re not alone. We’re here to support the growth of your program from a small sprout, all the way to market. Together, we can identify the building blocks – the framework, scale-up, and manufacturing – you need for success. Take our innovative drug substance questionnaire to discover which steps in your drug substance manufacturing process might be most effectively accomplished through a partnership, and receive a custom list of resources to help guide you through the process: https://hubs.ly/Q0361-4w0

    • 该图片无替代文字
  • 查看Resilience的组织主页

    42,770 位关注者

    Uncover critical quality attributes (CQAs) that correlate with clinical outcomes for your CAR-T cell therapy with unmatched precision. Kona Multiomics Characterization Assay Services uses multi-modal data combining mRNA and surface protein markers from the same single cells. Access accurate and reliable data generated by a state-of-the-art assay. Download the Kona fact sheet here and see the data: https://hubs.ly/Q037q_H10

  • 查看Resilience的组织主页

    42,770 位关注者

    Happy International Women's Day! Today, and every day, we celebrate the incredible achievements, resilience, and contributions of women around the world. This year’s theme is #AccelerateAction, a worldwide call to acknowledge that with the right action and support, positive progress can be made for women everywhere. We want to take a moment to recognize the impact that women make here at Resilience in all aspects of our work, from research and development to production and quality control, and digital innovation.?On this #IWD2025, let's continue to uplift, support, and amplify the voices of women everywhere, and recommit ourselves to creating a more equitable future for all.

    • 该图片无替代文字
  • 查看Resilience的组织主页

    42,770 位关注者

    Putting down roots with a CDMO partner is a big decision, and we want to ensure you can do it with confidence. Your product has its own unique growth curve, and determining if our manufacturing capacity and expertise is the right fit, is essential. We invite you to take our innovative questionnaire to discover which of our services might align with your drug product scale-up needs. At the end, you’ll receive a customized list of resources to help guide you through to your next phase. Learn more today: https://hubs.ly/Q03613rg0

    • 该图片无替代文字

相似主页

查看职位

融资